In colorectal cancer, miR-34a suppresses the expression of multidrug resistance protein 1 (MDR1) and enhances chemosensitivity to 5-FU by targeting LRPPRC, while P53 mutations foster chemoresistance by inhibiting miR-34a [31]. Here, ABCB1 is linked to colorectal cancer.